Daniel Vitt - 04 Jun 2025 Form 4/A - Amendment Insider Report for IMMUNIC, INC. (IMUX)

Reporting relationship: CEO and Director, Director
Issuer ticker: IMUX
Reported as of: 04 Jun 2025
Net transaction value: +$11,550
SEC form: 4/A - Amendment
Accepted by SEC: 20 Jun 2025, 17:15:45 UTC
Original report date: 06 Jun 2025
Prior SEC filing: 06 Dec 2024
Next SEC filing: 18 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Daniel Vitt

Key filing fact

Daniel Vitt filed Form 4/A - Amendment for IMMUNIC, INC. (IMUX) on 20 Jun 2025.

Key facts

This page summarizes Daniel Vitt's Form 4/A - Amendment filing for IMMUNIC, INC. (IMUX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Jun 2025, 17:15.

Change

Previous filing in this sequence was filed on 06 Dec 2024.
Current net transaction value: +$11,550.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001773673 Primary reporting owner

Vitt Daniel

Relationship: CEO and Director, Director
Address: 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK
Signature: /s/ Daniel Vitt
Signature date: 20 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMUX transaction

Common Stock

Purchase

Transaction value: $11,550
Shares: +15,000
Change %: +107%
Price: $0.7700
Shares after: 29,000
Date: 04 Jun 2025
Ownership: Direct
Footnotes: F1

IMUX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 362,877
Date: 04 Jun 2025
Ownership: See footnote
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMUX transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +1,558,000
Change %
Price: $0.000000
Shares after: 1,558,000
Date: 05 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,558,000
Exercise price: $0.7729
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The purchase was made in Euros and the price was converted into U.S. dollars based on the foreign currency exchange rate as of June 4, 2025 (at Euro 1.00 = U.S. dollar 1.1384).

Footnote F2

362,877 shares of the Issuer's common stock are owned by Listrax UG (haftungsbeschrankt). The RP is Managing Director of Listrax UG and exercises voting and dispositive power over such shares.

Footnote F3

25% of the shares underlying the option vest on the first anniversary of the grant date, with the remainder vesting in equal increments on each successive one-month anniversary thereafter for the next 36 months.

SEC remarks

This Form 4/A is being filed to amend the prior Form 4 filed by the Reporting Peron on June 6, 2025 to correct an administrative error that incorrectly reported the number of stock options granted.